21.20.Z - Manufacture of medicines and other pharmaceutical products
01.28.Z - Growing of spices, aromatic, drug and pharmaceutical crops
21.10.Z - Manufacture of basic pharmaceutical substances
46.45.Z - Wholesale of perfume and cosmetics
46.46.Z - Wholesale of pharmaceutical goods
46.90.Z - Non-specialised wholesale trade
72.19.Z - Other research and experimental development on natural sciences and engineering
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,9 | 0,4 | 0,7 | 58,9 |
EBITDA | 1,4 | 1 | 1,2 | 15,1 |
Short time liabilities | 13,1 | 9,9 | 7,8 | -20,7 |
Equity capital | 21,2 | 21,5 | 20,2 | -5,9 |
Operating profit (EBIT) | 0,9 | 0,6 | 0,7 | 25,7 |
Assets | 34,3 | 32,2 | 28,3 | -12,1 |
Net profit (loss) | 0,7 | 0,3 | 0,5 | 88,4 |
Cash | 0,3 | 0,6 | 2,6 | 319,8 |
Liabilities and provisions for liabilities | 13,1 | 10,7 | 8,1 | -24,3 |
Net income from sale | 39 | 39,6 | 37,7 | -4,8 |
Working assets | 31,5 | 29,3 | 25,4 | -13,4 |
Depreciation | 0,5 | 0,5 | 0,5 | 2,4 |
% | % | % | p.p. | |
Profitability of capital | 3,2 | 1,3 | 2,6 | 1,3 |
Equity capital to total assets | 61,9 | 66,7 | 71,3 | 4,6 |
Gross profit margin | 2,3 | 1,1 | 1,8 | 0,7 |
EBITDA Margin | 3,6 | 2,6 | 3,1 | 0,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 122 | 91 | 76 | -15 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane